Results 91 to 100 of about 18,898 (135)

Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials. [PDF]

Adv Ther
Ciudin A, Sapin H, Fan L, Dimitriadis GK, Zimner-Rapuch S, Curteis T, Clark LJ, Rubinstein M, Johansson E.   +8 more
europepmc   +1 more source

GLP-1 agonist liraglutide decreases operant methamphetamine intake in rats under conditions of short- but not extended-access to the drug. [PDF]

Front Pharmacol
Hrickova M, Demirci SF, Amchova P, Ruda-Kucerova J.   +3 more
europepmc   +1 more source

Indications, efficacy, and safety of glucagon-like peptide-1 receptor agonists in respiratory diseases: A systematic review. [PDF]

J Family Med Prim Care
Esmaeel MN, Esmaeel NN, Alhouli RM, Alghareeb NM, Bucheery RA, Booresli YW, Alasoosi RA, Alasoosi BA, Alrashidi AJ, Alawainati MA.   +9 more
europepmc   +1 more source

Efficacy comparison of dapagliflozin combined with liraglutide versus monotherapy in obese patients with heart failure. [PDF]

Medicine (Baltimore)
Zhou G, Liu A, Hu X, Qi G, Zhang Y.
europepmc   +1 more source

Targeting metabolism to protect fertility and healthy pregnancy with SGLT2 inhibitors and GLP-1RAs. [PDF]

Curr Opin Physiol
Flanary SM, Yoshida K, Alejandro EU, Townsend D.   +3 more
europepmc   +1 more source

Immediate allergy against glucagon-like peptide-1 receptor agonist liraglutide. [PDF]

Asia Pac Allergy
Özdemir Ö.
europepmc   +1 more source

Searching for New Pharmacological Treatments of Alcohol Use Disorder (AUD): Focus on GLP-1 Receptor Agonists. [PDF]

Int J Mol Sci
Zawilska JB, Zwierzyńska E, Wojcieszak J.   +2 more
europepmc   +1 more source

Rapid improvement of renal microcirculatory homeostasis by liraglutide following diabetes induction. [PDF]

Diabetes Obes Metab
Li Y, Liu W, Wang Y, Wang B, Xu X, Li B, Liu M, Zhang X, Xiu R.   +8 more
europepmc   +1 more source

Community Pharmacists' Knowledge and Counseling Competence on GLP-1 Receptor Agonists in Obesity and Type 2 Diabetes Care in Türkiye: A Cross-Sectional Study. [PDF]

Diabetes Metab Syndr Obes
Bayram-Ozgur D, Demirtürk E, Sar Y.
europepmc   +1 more source